Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
Abstract Background Glioblastoma is devastating cancer with a high frequency of occurrence and poor survival rate and it is urgent to discover novel glioblastoma-specific antigens for the therapy. Cancer-germline genes are known to be related to the formation and progression of several cancer types...
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
BMC
2020-07-01
|
| Edice: | BMC Cancer |
| Témata: | |
| On-line přístup: | http://link.springer.com/article/10.1186/s12885-020-07155-y |